# The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas

> **NCT01567475** · PHASE1 · COMPLETED · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 21 (actual)

## Conditions studied

- Non-Hodgkin's Lymphomas

## Interventions

- **DRUG:** Everolimus and rituximab

## Key facts

- **NCT ID:** NCT01567475
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-06
- **Final completion:** 2015-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567475, "The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01567475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*